Neuropsychiatric symptoms in the prodromal stages of dementia

Current Opinion in Psychiatry - Tập 27 Số 3 - Trang 230-235 - 2014
Florindo Stella1, Márcia Radanovic2, Márcio Luiz Figueredo Balthazar3, Paulo Renato Canineu4, Leonardo Cruz de Souza5, Orestes Vicente Forlenza2
1Biosciences Institute, UNESP – Universidade Estadual Paulista, Rio Claro, São Paulo; Laboratory of Neurosciences (LIM-27), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, São Paulo
2Laboratory of Neurosciences (LIM-27), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, São Paulo
3Department of Neurology, Medical Sciences School, University of Campinas, Campinas, São Paulo
4Gerontology Program, Pontifícia Universidade Católica de São Paulo, São Paulo, São Paulo; Laboratory of Neurosciences (LIM-27), Department and Institute of Psychiatry, Faculty of Medicine, University of São Paulo, São Paulo, São Paulo
5Neuropsychiatric Branch, Neurology Division, University Hospital, Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil

Tóm tắt

Từ khóa


Tài liệu tham khảo

Sperling, 2011, Toward defining the preclinical stages of Alzheimers disease: recommendations from the National Institute on Aging and the Alzheimers Association workgroup., Alzheimers Dement, 7, 280, 10.1016/j.jalz.2011.03.003

McKhann, 2011, The diagnosis of dementia due to Alzheimers disease: recommendations from the National Institute on Aging Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease., Alzheimers Dement, 7, 263, 10.1016/j.jalz.2011.03.005

Peters, 2012, Prevalence of neuropsychiatric symptoms in CIND and its subtypes: the Cache County Study., Am J Geriatr Psychiatry, 20, 416, 10.1097/JGP.0b013e318211057d

Diniz, 2009, To treat or not to treat A meta-analysis of the use of cholinesterase inhibitors in mild cognitive impairment for delaying progression to Alzheimers disease., Eur Arch Psychiatry Clin Neurosci, 259, 248, 10.1007/s00406-008-0864-1

Albert, 2011, The diagnosis of mild cognitive impairment due to Alzheimers disease: recommendations from the National Institute on Aging-Alzheimers Association workgroups on diagnostic guidelines for Alzheimers disease., Alzheimers Dement, 7, 270, 10.1016/j.jalz.2011.03.008

Forlenza, 2013, Mild cognitive impairment (Part II): biological markers for diagnosis and prediction of dementia in Alzheimers disease., Rev Bras Psiquiatr, 35, 284, 10.1590/1516-4446-2012-3505

Pereira, 2010, Profiles of functional deficits in mild cognitive impairment and dementia: benefits from objective measurement., J Int Neuropsychol Soc, 16, 297, 10.1017/S1355617709991330

Jack, 2010, Hypothetical model of dynamic biomarkers of the Alzheimers pathological cascade., Lancet Neurol, 9, 119, 10.1016/S1474-4422(09)70299-6

Lyketsos, 2011, Neuropsychiatric symptoms in Alzheimers disease., Alzheimers Dement, 7, 532, 10.1016/j.jalz.2011.05.2410

De Medeiros, 2010, The Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of a revised assessment of neuropsychiatric symptoms in dementia., Int Psychogeriatr, 22, 984, 10.1017/S1041610210000876

Stella, 2013, The Brazilian version of the Neuropsychiatric Inventory-Clinician rating scale (NPI-C): reliability and validity of assessment of neuropsychiatric symptoms in dementia., Int Psychogeriatr, 25, 1503, 10.1017/S1041610213000811

Ikonomovic, 2008, Postmortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimers disease., Brain, 131, 1630, 10.1093/brain/awn016

Nordberg, 2010, The use of PET in Alzheimer disease., Nat Rev Neurol, 6, 78, 10.1038/nrneurol.2009.217

Rollin-Sillaire, 2012, Contribution of single photon emission computed tomography to the differential diagnosis of dementia in a memory clinic., J Alzheimers Dis, 30, 833, 10.3233/JAD-2012-111067

De Souza, 2012, Neuroimaging in dementias., Cur Opin Psychiatry, 25, 473, 10.1097/YCO.0b013e328357b9ab

Mattsson, 2011, The Alzheimers Association external quality control program for cerebrospinal fluid biomarkers., Alzheimers Dement, 7, 386, 10.1016/j.jalz.2011.05.2243

Ballmaier, 2004, Localizing gray matter deficits in late-onset depression using computational cortical pattern matching methods., Am J Psychiatry, 161, 2091, 10.1176/appi.ajp.161.11.2091

Kramberger, 2012, Cerebrospinal fluid Alzheimer markers in depressed elderly subjects with and without Alzheimers disease., Dement Geriatr Cogn Disord, 2, 48, 10.1159/000334644

Rapp, 2006, Increased hippocampal plaques and tangles in patients with Alzheimer disease with a lifetime history of major depression., Arch Gen Psychiatry, 63, 161, 10.1001/archpsyc.63.2.161

Piccinni, 2013, Neurodegeneration, -amyloid and mood disorders: state of the art and future perspectives., Int J Geriatr Psychiatry, 28, 661, 10.1002/gps.3879

Diniz, 2010, Serum brain-derived neurotrophic factor level is reduced in antidepressant-free patients with late-life depression., World J Biol Psychiatry, 11, 550, 10.3109/15622970903544620

Diniz, 2013, Reduced serum nerve growth factor in patients with late-life depression., Am J Geriatr Psychiatry, 21, 493, 10.1016/j.jagp.2013.01.014

Rapp, 2008, Increased neurofibrillary tangles in patients with Alzheimer disease with comorbid depression., Am J Geriatr Psychiatry, 16, 168, 10.1097/JGP.0b013e31816029ec

Tsopelas, 2011, Neuropathological correlates of late-life depression in older people., Br J Psychiatry, 198, 109, 10.1192/bjp.bp.110.078816

Apostolova, 2007, Structural correlates of apathy in Alzheimers disease., Dement Geriatr Cogn Disord, 24, 91, 10.1159/000103914

Marshall, 2006, Neuropathologic correlates of apathy in Alzheimers disease., Dement Geriatr Cogn Disord, 21, 144, 10.1159/000090674

Dubois, 2007, Research criteria for the diagnosis of Alzheimers disease: revising the NINCDS-ADRDA criteria., Lancet Neurol, 6, 734, 10.1016/S1474-4422(07)70178-3

De Souza, 2012, CSF tau markers are correlated with hippocampal volume in Alzheimers disease., Neurobiol Aging, 33, 1253, 10.1016/j.neurobiolaging.2011.02.022

Geda, 2006, Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study., Arch Neurol, 63, 435, 10.1001/archneur.63.3.435

Flicker, 2008, Vascular factors in geriatric psychiatry: time to take a serious look., Curr Opin Psychiatry, 21, 551, 10.1097/YCO.0b013e32830ef736

Lee, 2012, Alzheimers Disease Neuroimaging Initiative. Depressive symptoms in mild cognitive impairment predict greater atrophy in Alzheimers disease-related regions., Biol Psychiatry, 71, 814, 10.1016/j.biopsych.2011.12.024

Stella, 2013, Validation of the Brazilian version of the Apathy Inventory., Int J Geriatr Psychiatry, 28, 979, 10.1002/gps.3917

Herrera-Guzman, 2010, Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on attention and executive functions in patients with major depressive disorder., Psychiatry Res, 177, 323, 10.1016/j.psychres.2010.03.006

Hashimoto, 2004, Critical role of brain-derived neurotrophic factor in mood disorders., Brain Res Rev, 45, 104, 10.1016/j.brainresrev.2004.02.003

Bhalla, 2006, Persistence of neuropsychological deficits in the remitted state of late-life depression., Am J Geriatr Psychiatry, 14, 419, 10.1097/01.JGP.0000203130.45421.69

Pelton, 2008, Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study., Int J Geriatr Psychiatry, 23, 670, 10.1002/gps.1958

Arean, 2010, Problem-solving therapy and supportive therapy in older adults with major depression and executive dysfunction., Am J Psychiatry, 167, 1391, 10.1176/appi.ajp.2010.09091327

Bragin, 2005, Integrated treatment approach improves cognitive function in demented and clinically depressed patients., Am J Alzheimers Dis Other Demen, 20, 21, 10.1177/153331750502000103

Stern, 2002, What is cognitive reserve Theory and research application of the reserve concept., J Int Neuropsychol Soc, 8, 448, 10.1017/S1355617702813248